Octagon Capital Advisors LP Kiniksa Pharmaceuticals, Ltd. Transaction History
Octagon Capital Advisors LP
- $639 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding KNSA
# of Institutions
165Shares Held
40.6MCall Options Held
186KPut Options Held
157K-
Black Rock Inc. New York, NY4.19MShares$78.3 Million0.0% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.2MShares$59.8 Million10.07% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E93.14MShares$58.5 Million1.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.98MShares$55.7 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.81MShares$52.5 Million0.7% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $644M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...